tbuckley/cabot-search huggingface dataset:
Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Final Progression-Free Survival Analysis of Part 1 of an Open-Label, Multicenter, Randomized, Phase 3 Trial (GMMG-HD7)
Authors: Hartmut Goldschmidt, Uta Bertsch, Ema Pozek, Axel Benner, Roland Fenk, Britta Besemer, Christine Hanoun, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Lisa Leypoldt, Bernhard Heilmeier, Stefanie Huhn, Sabine Vogel, Michael Hundemer, Christof Scheid, Igor Wolfgang Blau, Steffen Luntz, Tobias A.W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Evgenii Shumilov, Wolfgang Knauf, Christian Sebastian Michel, Thomas Geer, Hendrik Riesenberg, Christoph Lutz, Marc-Steffen Raab, Martin Hoffmann, Katja C. Weisel, Hans Salwender, Elias K. Mai
Journal: Blood (2024)
DNA Damage Repair Pathway Variants Are Frequent in Patients Undergoing CAR-T Cell Therapy for Lymphoma and Associated with Increased Risk of Myeloid Neoplasia Post Cytotoxic Therapy
Authors: Zhi Han Yeoh, Ing Soo Tiong, Mark R Dowling, Hamish W Scott, Nicole O'Leary, Samantha van der Linde, Tamia Nguyen, Simon J Harrison, Ashish Bajel, Andrew H Wei, Piers Blombery
Journal: Blood (2024)
Anti-HLA Antibody Specificities Are Differentially Associated with Immune Platelet Transfusion Refractoriness in Patients at Lower Calculated Panel Reactive Antibody (cPRA) Levels
Authors: Matthew Tanner, Aaron Boothby, Thejaswi Bikkani, Tiffany Hangse, Danny Youngs, Aaron Ing, Loren Gragert, Walter Dzik, Gana Balgansuren, Hamilton Tsang, Sandya R. Panch
Journal: Blood (2024)
Single-Cell Multi-Omic Profiling of Patients with BCMA-Targeted Therapy Identifies Molecular and Cellular Factors Associated with Responsiveness and Treatment Effects
Authors: Minghao Dang, Hans C. Lee, Hima Bansal, Maria Acevedo-Calado, Li Qin, Wei Tan, Luz Yurany Moreno Rueda, David Berrios, Krina K. Patel, Pei Lin, Sheeba K. Thomas, Donna M. Weber, Linghua Wang, Robert Z. Orlowski
Journal: Blood (2024)
<i>Phip Is a Potent Leukemia Oncogene Identified in Acute Myeloid Leukemia (AML) Patients of African Ancestry</i>
Authors: Bailee N. Kain, Sidharth Sen, Deedra Nicolet, Sierra N. Bennett, David Bernardicius, Yueh-Chiang Hu, Christopher Walker, Ann-Kathrin Eisfeld, Nathan Salomonis, H. Leighton Grimes
Journal: Blood (2024)
The Prognostic Impact of Myelodysplasia-Related Gene Mutations in Acute Myeloid Leukemia with <i>FLT3</i>-ITD Mutations
Authors: Rabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng, Razif Gabdoulline, Javier Martínez Elicegui, Marta Sobas, Lisa Pleyer, Maria Teresa Voso, Axel Benner, Alberto Hernández Sánchez, Jesse M. Tettero, Laura Tur, Klaus H Metzeler, Guadalupe Onate, Soren Lehmann, Brian J P Huntly, Ian Thomas, Felicitas R Thol, Florian Heidel, Peter J. M. Valk, Konstanze Döhner, Torsten Haferlach, Ken I Mills, Hartmut Döhner, Gastone Castellani, Gert Ossenkoppele, Jesus Maria Hernandez Rivas, Lars Bullinger, Michael Heuser
Journal: Blood (2024)
Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing - a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma
Authors: Anu Korula, Arun Arunachalam, Uday Kulkarni, Phaneendra Venkateswara Rao Datari, Sumith Mathew, Aswin Anand PAI, Sushil Selvarajan, Fouzia N., Aby Abraham, Biju George, Poonkuzhali Balasubramanian, Vikram Mathews
Journal: Blood (2024)
The Role of an Inflammatory Phenotype in Driving Clonal Evolution in B-Acute Lymphoblastic Leukemia
Authors: Danielle Wolfe Cohen, Clemence Aldebert, Emily Duan, Sylwia Jasinski, Xiaotu Ma, Heather L. Mulder, John Easton, Jiyuan Hu, Laura E. Hogan, David T. Teachey, Elizabeth A. Raetz, Nikki Evensen, William L. Carroll
Journal: Blood (2024)
PORT-77, a Novel and Potent Inhibitor of ABCG2, Protects Against Skin Photo Toxicity and Liver Damage in a Mouse Model of Erythropoietic Protoporphyria (EPP)
Authors: Bhavik Shah, Edmond Huang, Yvonne Pak, Chris Henry, Sunita Babbar, Athiwat Hutchaleelaha, Robert Zamboni, Xiaochao Ma, Pete Schmidt, Morgan Paull, Uma Sinha
Journal: Blood (2024)
Prognostic Value of the Measurable Residual Disease (MRD) in AML Treatment with Venetoclax in Combination with Hypomethylating Agents: Validation of the ELN 2021 MRD Recommendations
Authors: Carlos Jimenez-Vicente, Aina Cardus, Guillermo Ramil López, Guadalupe Onate, Iago Arribas, Sara Garcia-Avila, Lucia Gomez-Perez, Daniel Esteban, Antonella Sturla, Francesca Guijarro, Mònica López-Guerra, Sandra Castaño-Díez, Alexandra Martínez-Roca, Albert Cortés-Bullich, Amanda Isabel Perez, Ines Zugasti, Inés Monge-Escartin, Jorge Sierra, Susana Vives, Helena Pomares, Montserrat Arnan, Josep Nomdedeu, Ana Garrido, Marta Pratcorona, Marina Díaz-Beyá, Jordi Esteve
Journal: Blood (2024)
Monocyte-Driven Aberrant Inflammation in Myeloproliferative Neoplasms Is Regulated By Galectin-1
Authors: Fan He, Shuyang Lin, Tim Kong, Daniel Fisher, Alexander Kim, Molly Brakhane, Christopher Letson, Yanbo Yu, Noelle Champagne, Mary Fulbright, Varun Ramesh, Angelo Laranjeira, Maggie Cox, Katrina Ashworth, Stephen Sykes, Jorge Di Paola, Stephen Oh
Journal: Blood (2024)
Olverembatinib As Second-Line (2L) Therapy in Patients (pts) with Chronic Phase-Chronic Myeloid Leukemia (CP-CML)
Authors: Li Weiming, Yanli Zhang, Huanling Zhu, Yunfan Yang, Na Xu, Bingcheng Liu, Zi Chen, Wei Chu, Yifan Zhai, Yu Hu
Journal: Blood (2024)
The Composite Health Risk Assessment Model (CHARM) Predicts Risks of Toxicities, Functional and Cognitive Decline Among Survivors of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): A Prospective BMT-CTN Study 1704
Authors: Mohamed Sorror, Wael Saber, Brent R. Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William A. Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Asmita Mishra, Joseph Uberti, Parastoo B Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence E Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph E. Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew Artz
Journal: Blood (2024)
Posttranslational Changes in Histone Modification Driven By USP48 Loss Increase Sensitivity to Hypomethylating Agents in Acute Myeloid Leukemia
Authors: Constanze Schneider, Gabriela Alexe, Ashleigh Meyer, Lucy A Merickel, Allen T Basanthakumar, Audrey Taillon, Silvi Salhotra, Yara Rodriguez, Björn Häupl, David E. Root, Thomas Oellerich, Kimberly Stegmaier
Journal: Blood (2024)
Ropeginterferon Alfa-2b Induces Apoptosis and Differentiation of Leukemia Stem Cells and Separates GVL Effects from Gvhd after Allogeneic Hematopoietic Cell Transplantation
Authors: Yumika Saito, Daigo Hashimoto, Keisuke Kojima, Shihori Tsukamoto, Tomoe Ichiki, Toru Miyajima, Wenyu Li, Shinpei Harada, Zixuan Zhang, Hajime Senjo, Yuta Hasegawa, Takahide Ara, Takanori Teshima
Journal: Blood (2024)
Uncovering the Genetics of Poor and Exceptional Survivorship after Unrelated Donor Allogeneic Hematopoietic Cell Transplantation (HCT)
Authors: Angel Earle, Pankhil Shah, Susan E. Steck, Jiajia Zhang, Nadine El Kalach, Lara E. Sucheston-Campbell, Stephen R. Spellman, Marcelo C. Pasquini, Meilun He, Qianqian Zhu, Theresa E. Hahn, Alyssa I Clay-Gilmour
Journal: Blood (2024)
ELA026, a Monoclonal Antibody Targeting Signal Regulatory Protein-α/β1/γ, Rapidly Controls Inflammation and Improves 2-Month Survival in Treatment-Naïve Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Authors: Abhishek Maiti, Naval Daver, William T. Johnson, Gaurav Goyal, Catherine M. Broome, Satyen Gohil, Jan Van Laar, Javier Lopez Jimenez, David McCall, Hayley Lane, Benjamin Kim, Sandip Panicker, Gary Patou, Stephen Moore, Brian Mangal, Kelly Covert, Graham Carl Parry, Kathy Dong, Carl Allen, Swaminathan P Iyer
Journal: Blood (2024)
<i>Update on Monocentric CD19-CAR T-Cell Therapy in 30 Patients with Autoimmune Disease</i>
Authors: Fabian Mueller, Melanie Hagen, Andreas Wirsching, Soraya Kharboutli, Silvia Spoerl, Carlo Tur, Tobias Krickau, Laura Bucci, Christina Bergmann, Janina Auth, Panayiotis Garantziotis, Sebastian Boeltz, Sascha Kretschmann, Ingrid Vasova, Dimitrios Mougiakakos, Michael Aigner, Ricardo Grieshaber-Bouyer, Markus Metzler, Simon Voelkl, Georg Schett, Andreas Mackensen
Journal: Blood (2024)
Annualized Bleeding Rates in Patients with Hemophilia a or B and Inhibitors with and without Target Joints at Baseline: Results from the Concizumab Phase 3 Explorer7 Study
Authors: Amy D. Shapiro, Shashikant Apte, Ana Boban, Renée Brown Frandsen, Silvia Linari, Johnny Mahlangu, Camila Martins Mazini Tavares, Tadashi Matsushita, Salim Nekkal, Jameela Sathar, Anthony K C Chan
Journal: Blood (2024)
The Follicular Lymphoma and Chronic Lymphocytic Leukemia Proliferative Microenvironment at Single-Cell Resolution
Authors: Antonio Ferreira, Shumei Wang, Larysa Poluben, Joshua D Brandstadter, Eric Perkey, Steven Sotirakos, Mai Drew, Li Pan, Madeleine Lemieux, David Dorfman, Brent Shoji, Ivan Maillard, Steve Blacklow, Jon C. Aster
Journal: Blood (2024)
Whole Body CD8+ T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy
Authors: Jaap A. van Doesum, Kylie Keijzer, Janneke W. de Boer, Nienke A.M. Smit, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge, Frank R. Pierik, Gerwin A. Huls, Lisanne V. van Dijk, Lydia Visser, Arjan Diepstra, Walter Noordzij, Simon P. Williams, Alexander Ungewickell, Sjoerd G. Elias, Elisabeth G.E. de Vries, Anne G.H. Niezink, Tom van Meerten
Journal: Blood (2024)
Real-World Experience of Switching to Prophylactic Efanesoctocog Alfa in Patients with Moderate and Severe Hemophilia a: An Analysis of the Adelphi Hemophilia Wave III Disease Specific Programme
Authors: Maissaa Janbain, Miguel A. Escobar, Manuel Carcao, Andrew Wilson, Jennifer Dumont, Nathan Ball, Ella Morton, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi
Journal: Blood (2024)
CD33 Antibody-Modified Nanoparticles Encapsulated IL-15 Induce ISG15 to Promote MHC I Expression in Leukemia Cells Via Innate Immunity Pathway Inducing Graft-Versus-Leukemia without Aggravating Graft-Versus-Host Disease
Authors: Ruowen Wei, Ao Zhang, Moran Wang, Xie-Na Cao, Ruiqi Zhu, Shengling Ma, Linghui Xia, Wei Shi
Journal: Blood (2024)
Failure to Execute Caspase Activation Drives Therapy Resistance in <i>TP53</i> Mutated AML
Authors: Ahmed M Mamdouh, Fang Qi Lim, Yang Mi, Elyse A Olesinski, Yichen Wang, Shaista Shabbir Jasdanwala, Karanpreet Singh Bhatia, Xiao Xian Lin, Valeriia Sapozhnikova, Philipp Mertins, Brandon D. Brown, Yihua Qiu, Anthony G. Letai, Alexandre Puissant, Steven M. Kornblau, Jan Krönke, Edward Ayoub, Koji Itahana, Michael Andreeff, Shruti Bhatt
Journal: Blood (2024)
TENT5C As a Target of Chromatin Remodeler SMARCA2 Participates BTK Inhibitor Resistance in Mantle Cell Lymphoma By Regulating ATP Metabolism
Authors: Yuting Yan, Dandan Shan, Ying Yu, Weihao Chen, Xinyi Zhang, Xiong Wenjie, Tingyu Wang, Mu Hao, Gang An, Lu-Gui Qiu, Zhen Yu, Shuhua Yi
Journal: Blood (2024)
Second Infusion of CAR T-Cells in Patients with Relapsed /Refractory B-Cell Acute Lymphoblastic Leukemia: Results from a Gocart Coalition Analysis on Behalf of the PDWP, ALWP, and Ctiwp of the EBMT
Authors: Susana Rives, Giorgio Ottaviano, Nuria Martínez-Cibrián, Shatha Y. Farhan, Sowjanya Vuyyala, Jacques-Emmanuel Galimard, Eva Michel, Fizza Imran, Nazaret Sánchez-Sierra, Richard Mitchell, Stephan Mielke, Andishe Attarbaschi, Soeren Lykke Petersen, Samppa Ryhanen, Wolfgang Andreas Bethge, David Beauvais, Tsila Zuckerman, Antonio Pérez-Martínez, Krzysztof Kalwak, Fabio Ciceri, Annalisa Ruggeri, Julio Delgado, Sebastian Giebel, Adriana Balduzzi, Anna Alonso-Saladrigues, Valentin Ortiz-Maldonado
Journal: Blood (2024)
Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT
Authors: Sameem Abedin, Fateeha Furqan, Lyndsey Runaas, Walter Longo, Nirav N. Shah, Timothy S. Fenske, Marcelo C. Pasquini, William R Drobyski, Xue-Zhong Yu, Mehdi Hamadani
Journal: Blood (2024)
Mini-Dosed Blinatumomab Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute B-Cell Lymphoblastic Leukemia
Authors: Jie Ji, Zhigang Liu, Xinchuan Chen, Pu Kuang, Tian Dong, Hang Zhang, Ting Niu, Ting Liu
Journal: Blood (2024)
Metabolic Reprogramming By IDH1 Neomorph Epigenetically Guides CAR T Cell Differentiation
Authors: Kunho Chung, Dongxu Jiang, Xiaorong Gu, Jie Xu, Céline Grégoire, Beatriz Coutinho De Oliveira, Babal Kant Jha, J. Joseph Melenhorst
Journal: Blood (2024)
A Machine Learning-Based Workflow for Predicting Transplant Outcome in Patients with Sickle Cell Disease
Authors: Haiou Li, Vandana Sachdev, Xin Tian, My-Le Nguyen, Matthew Hsieh, Courtney D. Fitzhugh, Emily Limerick, Wynona Coles, Nancy Asomaning, Anna Conrey, Colin O. Wu, Swee Lay Thein
Journal: Blood (2024)
Real World Comparison of Efficacy and Safety of Fludarabine-Versus Bendamustine-Based Lymphodepleting Chemotherapy for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Relapse/Refractory (r/r) Large B-Cell Lymphoma (LBCL)
Authors: Alaa Ali, Nausheen Ahmed, Soyoung Kim, Matthew Bye, Sayeef Mirza, Alex Gordon Sieg, Christopher Strouse, Kalyan Nadiminti, Priyanka A. Pophali, Rammurti T. Kamble, Lohith Gowda, Cameron J. Turtle, Christine L. Phillips, Marcelo C. Pasquini, Sairah Ahmed, Siddhartha Ganguly, Amy Moskop
Journal: Blood (2024)
Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study
Authors: Robert Klamroth, Stephanie P'ng, Sophie Susen, Davide Matino, Pratima Chowdary, Angela C Weyand, Toshko Lissitchkov, Young-Shil Park, María Teresa Alvarez-Román, Liqi Feng, Helena Palmborg, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Keiji Nogami
Journal: Blood (2024)
PARP Inhibitor Treatment Increases DNA Damage in Bone Marrow and Drives Compensatory Changes in Multiple Hematopoietic Stem and Progenitor Cell Populations Contingent on <i>Brca1</i> Genotype
Authors: Sarah Obregon, Dalton McLean, Sarah Miller, Amer Mohiuddin, Heather Hardin, Fauzia Hollnagel, Jane E Churpek
Journal: Blood (2024)
Clinical and Economic Outcome Analysis of First-Line Immunosuppression in Acquired Hemophilia a
Authors: Ellen Cusano, Julia Hews-Girard, Mujtaba Basharat, Lindsay Cowley, Julie Grabell, Nancy Hodgson, Kelly Pittman, Allison Rupnaraine, Rowan Thillaye-Kerr, Brendan Cord Lethebe, Paula James, Roy Khalife, Natasha Pardy, Chai W. Phua, Oksana C. Prokopchuk-Gauk, Michelle Sholzberg, Haowei Linda Sun, Man-Chiu Poon, M. Dawn Goodyear
Journal: Blood (2024)
Self-Rated Health Is an Independent Predictor of Subsequent Late Mortality after Blood or Marrow Transplantation (BMT) Among Survivors of Myeloid Malignancies: A BMTSS Report
Authors: Nora Balas, Joshua Richman, Wendy Landier, Sadeep Shrestha, Katia J Bruxvoort, Lindsey Hageman, Qingrui Meng, Elizabeth Ross, Alysia Bosworth, Hok Sreng Te, F. Lennie Wong, Ravi Bhatia, Stephen J. Forman, Saro Armenian, Daniel Weisdorf, Smita Bhatia
Journal: Blood (2024)
Disrupting IL10 Signaling Overcomes Compound Copy Number Variation-Driven Clinical Resistance to CDK4/6 and BTK Inhibition in Mantle Cell Lymphoma
Authors: Maurizio Di Liberto, Yang Hu, Xiangao Huang, Giorgio Inghirami, Kevin Wang, Christina Y. Lee, Kami J. Maddocks, Kristie A. Blum, Jia Ruan, John P. Leonard, Nancy L. Bartlett, Peter Martin, Olivier Elemento, Selina Chen-Kiang
Journal: Blood (2024)
Salvage Reinduction Chemotherapy Versus Alternative Regimens after Failed AML Intensive Induction Regimen, a Single Center Experience
Authors: Yomna Abu-Farsakh, Daniel P. Nurse, Jessica El-Asmar, Ameed Bawwab, Moath Albliwi, John Hanna, Asad Rauf, Heya Batah, Hasan Abuamsha, Emily C. Zabor, Yohana B. Bedelu, Mark Jinan Chen, Joy Nakitandwe, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Sudipto Mukherjee, Anjali S. Advani, Hetty E. Carraway, Moaath K. Mustafa Ali
Journal: Blood (2024)
TCL1A Is Associated with Blinatumomab Response and Immune Activation in Pediatric B-ALL
Authors: Andrew Hughes, Rawan Shraim, Lahari Uppuluri, Haley Newman, Gongping Shi, Julie Asare, Theresa Ryan, Elizabeth A. Raetz, James A. Whitlock, Maureen M. O'Brien, Deepa Bhojwani, Rachel E. Rau, Kara L. Davis, Stacy Cooper, Patrick Brown, Stephen P. Hunger, Mignon L. Loh, Laura E. Hogan, Stephan A. Grupp, Jun J. Yang, David T. Teachey, Caroline Diorio
Journal: Blood (2024)
The Impact of Weight Loss Grading Scale, a Measure of Cancer Cachexia, on Clinical Outcomes in Patients with Acute Myeloid Leukemia
Authors: Abdur Rahman Jabir, Anna Lisa Ciarrocca, Nathaniel O'Connell, Kelly Needles, Timothy S Pardee, Rupali Bhave, Leslie R Ellis, Matthew J. Wieduwilt, Bayard L Powell, Madelyn Burkart
Journal: Blood (2024)
Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party
Authors: Imke E. Karsten, Norbert Schmitz, Mathilde Fekom, Laurence de Leval, Hervé Finel, Irma Khvedelidze, Won Seog Kim, Depei Wu, Montserrat Rovira, Fengrong WANG, Xiao-Jun Huang, Peter Dreger, Johan Maertens, Paolo Corradini, Grzegorz Helbig, Wolfgang Andreas Bethge, Larry Bacon, Jan Vydra, Aitana Balaguer Rosello, Matthias Stelljes, Georg Lenz, Alina Daniela Tanase, Anna Sureda Balari, Ali Bazarbachi, Bertram Glass
Journal: Blood (2024)
<i>18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting</i>
Authors: Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Ame, Marion Simonet, Hyacinthe A Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Charlotte Doublet, Stéphane Morisset, Romaine Mayet, Gwenaëlle Garin, Stéphanie Dulucq, Françoise Huguet
Journal: Blood (2024)
Older Age and <i>TP53</i> Mutations Are Predictors for the Development of Therapy-Related Myeloid Neoplasms in Adults Undergoing Frontline Therapy for Acute Lymphoblastic Leukemia
Authors: Roberta Santos Azevedo, Hagop M. Kantarjian, Koichi Takahashi, Cedric Christophe Nasnas, Sanam Loghavi, Nitin Jain, Fadi G. Haddad, Jayastu Senapati, Ghayas C. Issa, Hussein A. Abbas, Tapan M. Kadia, Kelly S. Chien, Guillermo Montalban-Bravo, Rebecca Garris, Farhad Ravandi, Elias Jabbour, Nicholas J. Short
Journal: Blood (2024)
A Phase 1b/2 Study of the Efficacy and Safety of Combination Hydroxyurea and Dose-Escalated Erythropoietin for Treatment of Anemia in Sickle Cell Disease (ACHiEvE-SCD)
Authors: Titilope A Adeyemo, Nelly Kiriza, Feyisayo T. Oluwole, Mark Jelinek, Jude Jonassaint, Olubusola Oluwole, Christine Saber, Brian J Philips, Olusegun-Joseph D Akinsanya, Vincent O Osunkalu, Laura M. DeCastro, Enrico M Novelli, Julia Z Xu
Journal: Blood (2024)
MCL1 Promotes Fatty Acid β-Oxidation in Therapy-Resistant AML through Cytoplasmic Sequestration of the Transcriptional Repressor IRF2BP2
Authors: Mark J Althoff, Mohd Minhajuddin, Brett M Stevens, Austin E Gillen, Regan Miller, Ana Vujovic, Sweta B Patel, William Showers, Stephanie Gipson, Monika Dzieciatkowska, Jana M Ellegast, Tristen Wright, Kimberly Stegmaier, Joseph T Opferman, Craig T Jordan
Journal: Blood (2024)
Tracing Clonal Hematopoiesis and Tumor-Specific Mutations in Hematopoietic Progenitors of B Cell Non-Hodgkin Lymphoma (NHL) Patients
Authors: Laura Wiegand, Patricia Silva, Daniel Noerenberg, Friederike Christen, Marlon Tilgner, Robert Altwasser, Klara Kopp, Benjamin N. Locher, Pelle F. Löwe, Catarina M. Stein, Vanessa Storzer, Franziska Briest, Jana Ihlow, Anna Dolnik, Naveed Ishaque, Ulrich Keller, Livius Penter, Lars Bullinger, Raphael Hablesreiter, Frederik Damm
Journal: Blood (2024)
A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment
Authors: Xiaodong Mo, He Huang, Feng Chen, Yi Luo, Jia Chen, Erlie Jiang, Yicheng Zhang, Linghui Xia, Chengwei Luo Luo, Xinchuan Chen, Nainong Li, Ming Jiang, Sujun Gao, Dongqin Yang, Qingli Zuo, Yimin Chen, Li Yao, Pan Liang, Depei Wu
Journal: Blood (2024)
Deep Learning Predicts Risk of Large B-Cell Lymphoma Progression upon R-CHOP Therapy from Baseline Histology
Authors: Samaneh Abbasi Sureshjani, Anil Yüce, Christian Doerig, Agata Mosinska, Patrick Kimes, Murali Kesavan, Connie Lee Batlevi, Yanwen Jiang, Markus D Herrmann
Journal: Blood (2024)
Identifying Trial-Eligible High- and High-Intermediate Risk Patients with Diffuse Large B-Cell Lymphoma Using Prognostic Models: A Real-Life Comparative Analysis of IPI, aaIPI and NCCN-IPI from Danish Study Group
Authors: Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Tarec Christoffer Christoffer El-Galaly, Thomas Stauffer Larsen
Journal: Blood (2024)
HLA-Pan-DP CAR-T Demonstrates Cytotoxicity Against Multiple Hematological Malignancies
Authors: Hiroyuki Takamatsu, Emilio Ramos, Bonell Patino-Escobar, Corynn Kasap, Adila Izgutdina, Juwita Werner, Akihito Inagaki, Takeshi Yoroidaka, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Veronica Steri, Elliot Stieglitz, Masaki Nagato, Satoshi Tatsuno, Arun P Wiita
Journal: Blood (2024)
A Phase II Trial of Venetoclax in Combination with Cladribine, Idarubicin, and Cytarabine in Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Authors: Ian M. Bouligny, Hagop M. Kantarjian, Musa Yilmaz, Naval Daver, Gautam Borthakur, Courtney D. DiNardo, Guillermo Montalban-Bravo, Nicholas J. Short, Yesid Alvarado Valero, Elias Jabbour, Nitin Jain, Naveen Pemmaraju, Danielle Hammond, Kelly S. Chien, Koichi Takahashi, Ghayas C. Issa, Hussein A. Abbas, Guillermo Garcia-Manero, Farhad Ravandi, Tapan M. Kadia
Journal: Blood (2024)
Systematic Evaluation of GAPs and Gefs Identifies ARHGAP45 As a Targetable Leukemia-Specific Dependency
Authors: Pu Zhang, Zhendong Cao, Xiangyu Pan, Yuqiao Liu, Cynthia Castro, Won Jun Kim, Takeshi Fujino, Jennifer Lewis, Jahan Rahman, Sanam Shahid, Jasmine S. Um, Erin R. Burns, Bing-Yi Chen, Winson Cai, Juliana Ortiz-Pacheco, Zhuoning Li, Mara Monetti, Anthony F. Daniyan, Christopher R. Vakoc, Omar Abdel-Wahab, Junwei Shi
Journal: Blood (2024)
Efficacy and Safety of Odronextamab Monotherapy in Patients (Pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Progressing after CAR T-Cell Therapy: Primary Analysis from the ELM-1 Study
Authors: Matthew Matasar, Max S. Topp, John N. Allan, Stephen M. Ansell, Jeffrey A. Barnes, Jon E. Arnason, Jean-Marie Michot, Neta Goldschmidt, Susan M. O'Brien, Uri Abadi, Irit Avivi Mazza, Jingxian Cai, Julia Zecchini, Min Zhu, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Jennifer L. Crombie
Journal: Blood (2024)
Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia
Authors: Francisco Marchi, Ann-Kathrin Schade, Vivek M. Shastri, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Jeffery M Klco, Alan S Gamis, Rhonda E. Ries, Anders Kolb, Richard Aplenc, Todd A. Alonzo, Stanley Pounds, Soheil Meshinchi, Jatinder K. Lamba
Journal: Blood (2024)